Innocoll gains FDA nod for drug-device pain therapy Xaracoll Aug. 31, 2020 By Randy Osborne No Comments The FDA came through at last for Athlone, Ireland-based Innocoll Holdings Ltd., greenlighting the drug-device combo Xaracoll (bupivacaine HCl) for acute postsurgical pain relief for up to 24 hours in adults after open inguinal hernia repair.Read More